Statin therapy is associated with lower prevalence of gut microbiota dysbiosis.

Bacteroides / isolation & purification Cohort Studies Cross-Sectional Studies Dysbiosis / epidemiology Faecalibacterium / isolation & purification Feces / microbiology Female Gastrointestinal Microbiome / drug effects Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors / administration & dosage Inflammatory Bowel Diseases / microbiology Male Obesity / microbiology Prevalence

Journal

Nature

ISSN: 1476-4687

Titre abrégé: Nature

Pays: England

ID NLM: 0410462

Informations de publication

Date de publication:
05 2020

Historique:

received: 05 08 2019

accepted: 03 04 2020

pubmed: 21 5 2020

medline: 1 7 2020

entrez: 21 5 2020

Statut: ppublish

Résumé

Microbiome community typing analyses have recently identified the Bacteroides2 (Bact2) enterotype, an intestinal microbiota configuration that is associated with systemic inflammation and has a high prevalence in loose stools in humans

Identifiants

DOI: 10.1038/s41586-020-2269-x PMID: 32433607

pubmed: 32433607

doi: 10.1038/s41586-020-2269-x

pii: 10.1038/s41586-020-2269-x

doi:

Substances chimiques

Hydroxymethylglutaryl-CoA Reductase Inhibitors 0

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

Pagination

310-315

Investigateurs

Renato Alves (R)

Chloe Amouyal (C)

Ehm Astrid Andersson Galijatovic (EAA)

Olivier Barthelemy (O)

Jean-Paul Batisse (JP)

Magalie Berland (M)

Randa Bittar (R)

Hervé Blottière (H)

Frederic Bosquet (F)

Rachid Boubrit (R)

Olivier Bourron (O)

Mickael Camus (M)

Dominique Cassuto (D)

Cecile Ciangura (C)

Jean-Philippe Collet (JP)

Maria-Carlota Dao (MC)

Jean Debedat (J)

Morad Djebbar (M)

Angélique Doré (A)

Line Engelbrechtsen (L)

Soraya Fellahi (S)

Sebastien Fromentin (S)

Philippe Giral (P)

Marianne Graine (M)

Agnes Hartemann (A)

Bolette Hartmann (B)

Gerard Helft (G)

Serge Hercberg (S)

Malene Hornbak (M)

Richard Isnard (R)

Sophie Jaqueminet (S)

Niklas Rye Jørgensen (NR)

Hanna Julienne (H)

Johanne Justesen (J)

Judith Kammer (J)

Mathieu Kerneis (M)

Jean Khemis (J)

Nikolaj Krarup (N)

Michael Kuhn (M)

Aurélie Lampuré (A)

Véronique Lejard (V)

Florence Levenez (F)

Lea Lucas-Martini (L)

Robin Massey (R)

Nicolas Maziers (N)

Jonathan Medina-Stamminger (J)

Lucas Moitinho-Silva (L)

Gilles Montalescot (G)

Sandrine Moutel (S)

Laetitia Pasero Le Pavin (LP)

Christine Poitou-Bernert (C)

Francoise Pousset (F)

Laurence Pouzoulet (L)

Sebastian Schmidt (S)

Johanne Silvain (J)

Mathilde Svendstrup (M)

Timothy Swartz (T)

Thierry Vanduyvenboden (T)

Camille Vatier (C)

Eric Verger (E)

Stefanie Walther (S)

Commentaires et corrections

Type : CommentIn

Références

Vandeputte, D. et al. Quantitative microbiome profiling links gut community variation to microbial load. Nature 551, 507–511 (2017).

pubmed: 29143816

Vieira-Silva, S. et al. Quantitative microbiome profiling disentangles inflammation- and bile duct obstruction-associated microbiota alterations across PSC/IBD diagnoses. Nat. Microbiol. 4, 1826–1831 (2019).

pubmed: 31209308

Probert, C. S., Emmett, P. M. & Heaton, K. W. Some determinants of whole-gut transit time: a population-based study. QJM 88, 311–315 (1995).

pubmed: 7796084

Ford, E. S. Body mass index, diabetes, and C-reactive protein among U.S. adults. Diabetes Care 22, 1971–1977 (1999).

pubmed: 10587828

Turnbaugh, P. J. et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027–1031 (2006).

pubmed: 17183312

Sze, M. A. & Schloss, P. D. Looking for a signal in the noise: revisiting obesity and the microbiome. MBio 7, e01018-16 (2016).

pubmed: 27555308 pmcid: 4999546

Walters, W. A., Xu, Z. & Knight, R. Meta-analyses of human gut microbes associated with obesity and IBD. FEBS Lett. 588, 4223–4233 (2014).

pubmed: 25307765 pmcid: 5050012

Le Chatelier, E. et al. Richness of human gut microbiome correlates with metabolic markers. Nature 500, 541–546 (2013).

pubmed: 23985870

Karlsson, F. H. et al. Symptomatic atherosclerosis is associated with an altered gut metagenome. Nat. Commun. 3, 1245 (2012).

pubmed: 23212374 pmcid: 3538954

Falony, G. et al. Population-level analysis of gut microbiome variation. Science 352, 560–564 (2016).

pubmed: 27126039

Vieira-Silva, S. et al. Species-function relationships shape ecological properties of the human gut microbiome. Nat. Microbiol. 1, 16088 (2016).

pubmed: 27573110

Alberti, K. G. M. M., Zimmet, P. & Shaw, J. Metabolic syndrome—a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet. Med. 23, 469–480 (2006).

pubmed: 16681555

Depommier, C. et al. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nat. Med. 25, 1096–1103 (2019).

pubmed: 31263284 pmcid: 6699990

Yun, Y. et al. Comparative analysis of gut microbiota associated with body mass index in a large Korean cohort. BMC Microbiol. 17, 151 (2017).

pubmed: 28676106 pmcid: 5497371

Quévrain, E. et al. Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn’s disease. Gut 65, 415–425 (2016).

pubmed: 26045134

Louis, P. et al. Restricted distribution of the butyrate kinase pathway among butyrate-producing bacteria from the human colon. J. Bacteriol. 186, 2099–2106 (2004).

pubmed: 15028695 pmcid: 374397

Litvak, Y., Byndloss, M. X. & Bäumler, A. J. Colonocyte metabolism shapes the gut microbiota. Science 362, eaat9076 (2018).

pubmed: 30498100 pmcid: 6296223

Kriss, M., Hazleton, K. Z., Nusbacher, N. M., Martin, C. G. & Lozupone, C. A. Low diversity gut microbiota dysbiosis: drivers, functional implications and recovery. Curr. Opin. Microbiol. 44, 34–40 (2018).

pubmed: 30036705 pmcid: 6435260

Ding, T. & Schloss, P. D. Dynamics and associations of microbial community types across the human body. Nature 509, 357–360 (2014).

pubmed: 24739969 pmcid: 4139711

Gardiner, B. J. et al. Clinical and microbiological characteristics of Eggerthella lenta bacteremia. J. Clin. Microbiol. 53, 626–635 (2015).

pubmed: 25520446 pmcid: 4298500

Mazmanian, S. K., Liu, C. H., Tzianabos, A. O. & Kasper, D. L. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 122, 107–118 (2005).

Wexler, H. M. Bacteroides: the good, the bad, and the nitty-gritty. Clin. Microbiol. Rev. 20, 593–621 (2007).

pubmed: 17934076 pmcid: 2176045

Ridker, P. M. et al. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial. Lancet 373, 1175–1182 (2009).

pubmed: 19329177

Muscogiuri, G. et al. The good and bad effects of statins on insulin sensitivity and secretion. Endocr. Res. 39, 137–143 (2014).

pubmed: 25208056

Khan, T. J. et al. Effect of atorvastatin on the gut microbiota of high fat diet-induced hypercholesterolemic rats. Sci. Rep. 8, 662 (2018).

pubmed: 29330433 pmcid: 5766553

Maier, L. et al. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature 555, 623–628 (2018).

pubmed: 29555994 pmcid: 6108420

Forslund, K. et al. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature 528, 262–266 (2015).

pubmed: 26633628 pmcid: 4681099

Zeiser, R. Immune modulatory effects of statins. Immunology 154, 69–75 (2018).

pubmed: 29392731 pmcid: 5904709

Grip, O., Janciauskiene, S. & Bredberg, A. Use of atorvastatin as an anti-inflammatory treatment in Crohn’s disease. Br. J. Pharmacol. 155, 1085–1092 (2008).

pubmed: 18806816 pmcid: 2597264

Ungaro, R. et al. Statins associated with decreased risk of new onset inflammatory bowel disease. Am. J. Gastroenterol. 111, 1416–1423 (2016).

pubmed: 27296939

Valles-Colomer, M. et al. The neuroactive potential of the human gut microbiota in quality of life and depression. Nat. Microbiol. 4, 623–632 (2019).

pubmed: 30718848

Touch, S. et al. Mucosal-associated invariant T (MAIT) cells are depleted and prone to apoptosis in cardiometabolic disorders. FASEB J. 32, 5078–5089 (2018).

Criscuolo, A. & Brisse, S. AlienTrimmer: a tool to quickly and accurately trim off multiple short contaminant sequences from high-throughput sequencing reads. Genomics 102, 500–506 (2013).

pubmed: 23912058

Li, J. et al. An integrated catalog of reference genes in the human gut microbiome. Nat. Biotechnol. 32, 834–841 (2014).

pubmed: 24997786

Cotillard, A. et al. Dietary intervention impact on gut microbial gene richness. Nature 500, 585–588 (2013).

pubmed: 23985875

Prifti, E. & Le Chatelier, E. MetaOMineR: a quantitative metagenomics data analyses pipeline. R package v.1.1 (2015).

Kultima, J. R. et al. MOCAT2: a metagenomic assembly, annotation and profiling framework. Bioinformatics 32, 2520–2523 (2016).

pubmed: 27153620 pmcid: 4978931

Nielsen, H. B. et al. Identification and assembly of genomes and genetic elements in complex metagenomic samples without using reference genomes. Nat. Biotechnol. 32, 822–828 (2014).

pubmed: 24997787

Prest, E. I., Hammes, F., Kötzsch, S., van Loosdrecht, M. C. M. & Vrouwenvelder, J. S. Monitoring microbiological changes in drinking water systems using a fast and reproducible flow cytometric method. Water Res. 47, 7131–7142 (2013).

pubmed: 24183559

Kultima, J. R. et al. MOCAT: a metagenomics assembly and gene prediction toolkit. PLoS ONE 7, e47656 (2012).

pubmed: 23082188 pmcid: 3474746

Falony, G., Vieira-Silva, S. & Raes, J. Microbiology meets big data: the case of gut microbiota-derived trimethylamine. Annu. Rev. Microbiol. 69, 305–321 (2015).

pubmed: 26274026

Darzi, Y., Falony, G., Vieira-Silva, S. & Raes, J. Towards biome-specific analysis of meta-omics data. ISME J. 10, 1025–1028 (2016).

pubmed: 26623543

Oksanen, J. et al. vegan: Community Ecology Package. R package v.2.2-1 (2015).

McMurdie, P. J. & Holmes, S. phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. PLoS ONE 8, e61217 (2013).

pubmed: 23630581 pmcid: 3632530

Ogle, D. H. FSA: Fisheries Stock Analysis. R package v.0.8.13. (2017).

Hothorn, T., Hornik, K., van de Wiel, M. A. & Zeileis, A. A Lego system for conditional inference. Am. Stat. 60, 257–263 (2006).

Morgan, M. DirichletMultinomial: Dirichlet-multinomial mixture model machine learning for microbiome data. R package v.1.18.0 (2017).

Harrell, F. E. Hmisc: Harrell Miscellaneous. R package v.4.1-1 (2018).

Fox, J. & Weisberg, S. An R Companion to Applied Regression. (Sage, 2011).

Lüdecke, D. sjstats: Statistical Functions for Regression Models v.0.17.5 (2019).

Venables, W. N. & Ripley, B. D. Modern Applied Statistics with S. (Springer, 2002).

Holmes, I., Harris, K. & Quince, C. Dirichlet multinomial mixtures: generative models for microbial metagenomics. PLoS ONE 7, e30126 (2012).

pubmed: 22319561 pmcid: 3272020

Duvallet, C., Gibbons, S. M., Gurry, T., Irizarry, R. A. & Alm, E. J. Meta-analysis of gut microbiome studies identifies disease-specific and shared responses. Nat. Commun. 8, 1784 (2017).

pubmed: 29209090 pmcid: 5716994

Grant, R. L. Converting an odds ratio to a range of plausible relative risks for better communication of research findings. Br. Med. J. 348, f7450 (2014).